Merit Medical Systems reported $41M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
3M USD 933M 280M Jun/2026
Abbott USD 928M 149M Jun/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Anika Therapeutics USD 292K 2.62M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cooper Companies USD 432.8M 510.7M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Haemonetics USD 33.01M 53.16M Jun/2026
ICU Medical USD 19.09M 11.04M Jun/2026
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.47B 227M Jun/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Olympus JPY 19.1B 5.71B Jun/2026
Pfizer USD -248M 2.94B Jun/2026
STAAR Surgical USD 8.06M 2.85M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026